Katherine J. Myall
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study.
Journal: The Lancet regional health. Europe
Published: December 05, 2024
Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease.
Journal: Life (Basel, Switzerland)
Published: August 10, 2024
Antifibrotic therapy in progressive pulmonary fibrosis: a review of recent advances.
Journal: Expert review of respiratory medicine
Published: July 23, 2024
What causes cough in pulmonary fibrosis, and how should we treat it?
Journal: Current opinion in pulmonary medicine
Published: June 24, 2024
Patient Perception of Cough in Interstitial Lung Disease; Impact of Cough Hypersensitivity.
Journal: Lung
Published: May 09, 2024
Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease.
Journal: Chest
Published: January 18, 2023
Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study.
Journal: ERJ open research
Published: August 20, 2022
How COVID-19 interacts with interstitial lung disease.
Journal: Breathe (Sheffield, England)
Published: December 09, 2021
Reply: A Role for Steroids in COVID-19-associated Pneumonitis at Six-Week Follow-Up?
Journal: Annals of the American Thoracic Society
Published: March 18, 2021
Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
Journal: Annals of the American Thoracic Society
Published: January 12, 2021
The burden of progressive fibrotic interstitial lung disease across the UK.
Journal: The European respiratory journal
Published: October 19, 2020
Last Updated: 09/26/2026